Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-20

Clinical Trial Update: Levosimendan in Patients With Impaired Right Ventricular Function Undergoing Cardiac Surgery [Phase 2]

View source ↗

Summary

A phase 2 clinical trial investigating levosimendan in patients with impaired right ventricular function undergoing open-heart surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levosimendan (levosimendan)

Snippet

Sponsor: Ain Shams University | Conditions: Right Heart Failure, Open-heart Surgery | Phase 2 | Status: UNKNOWN